Revolution Medicines Enters Major Headquarters Lease Agreement for ~672,000 Sq. Ft.
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 Revolution Medicines, Inc. ($RVMD) has filed an 8-K disclosing entry into four lease agreements for a new headquarters comprising approximately 672,000 RSF in Redwood City, California.
• Premises: 1600, 1700, 1800, and 1900 Seaport Blvd, Redwood City, CA • Lease Term: Staggered commencement (Sept 2027–Sept 2028) expiring September 2042 with extension options • Financials: Initial aggregate base rent of ~$2.7M/month (3% annual escalations), $23.1M rent abatement, and $115.9M standard TI allowance (plus up to $40.3M additional TI)
Comprehensive Analysis
Event Overview
On August 27, 2026, Revolution Medicines, Inc. agreed to lease four buildings totaling approximately 672,000 rentable square feet at 1600, 1700, 1800, and 1900 Seaport Boulevard in Redwood City, California, intended to serve as its new corporate headquarters.
Key Lease Terms
- Commencement & Term: Staggered commencement from September 26, 2027 through September 1, 2028, with initial terms running through September 2042 (with three 5-year extension options at fair market rent).
- Rent Structure: Aggregate scheduled monthly base rent starts at approximately $2.7 million upon full commencement, escalating at roughly 3% annually.
- Concessions & Allowances: Includes ~$23.1 million in rent abatement extending through January 2030, a standard tenant improvement allowance of ~$115.9 million, and an option for up to ~$40.3 million in additional tenant improvement allowances amortized at 10% per annum.
- Related Party Context: Investment funds managed by Farallon Capital Management, L.L.C. (which beneficially owned ~6.4% of RVMD common stock as of June 30, 2026) indirectly hold a majority interest in the landlord entities.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.